Hookipa Pharma Inc Reports Results For The Quarter Ended In June: Earnings Summary

Hookipa Pharma

08/08/2024 23:43

* HOOKIPA Pharma Inc  HOOK.OQ  reported a quarterly adjusted
loss
of $1.52​​ per share for the quarter ended in June, higher than
the same quarter last year, when the company reported EPS of
$-2.20.  The mean expectation of four analysts for the quarter
was for a loss of $1.25 per share. Wall Street expected
results to range from $-1.53 to -60 cents per share.
    * Revenue fell 51.8% to $1.29 million from a year ago;
analysts
expected $7.09 million. 
    * HOOKIPA Pharma Inc's reported EPS for the quarter was a
loss of
$1.52​.
    * The company reported a quarterly loss of $19.1 million.
    * HOOKIPA Pharma Inc shares had fallen by 17.0% this
quarter and
lost 39.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 19.3%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for HOOKIPA Pharma
Inc is $45.00 
This summary was machine generated from LSEG data August 8 at
10:42 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -1.25          -1.52          Missed
 Mar. 31 2024      -1.02          1.10           Beat
 Dec. 31 2023      -1.93          -2.20          Missed
 Sep. 30 2023      -2.10          -1.70          Beat